AZGP1 anticorps (N-Term)

N° du produit ABIN452775

Détail du produit anti-AZGP1 anticorps

Antigène: AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))

Épitope: N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp AZGP1 est non-conjugé

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Specificité: This antibody detects AZGP1 at N-term.

Réactivité croisée (Details): Species reactivity (tested):Human

Purification: Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS

Immunogène: KLH conjugated synthetic peptide selected from the N-terminal region of human AZGP1

Information d'application

Indications d'application: Western blot: 1: 50 - 1: 100. ELISA: 1: 1,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS with 0.09 % (W/V) sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.

Détails sur AZGP1

Antigène: AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))

Autre désignation: AZGP1 (AZGP1 Produits)

Synonymes: anticorps Zag, anticorps ZA2G, anticorps ZAG, anticorps ZA2GA, anticorps Zna2gp, anticorps alpha-2-glycoprotein 1, zinc, anticorps alpha-2-glycoprotein 1, zinc-binding, anticorps Azgp1, anticorps AZGP1

Sujet: AZGP1 stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. It may bind polyunsaturated fatty acids.Synonyms: ZAG, ZNGP1, Zinc-alpha-2-glycoprotein

Poids moléculaire: 33872 Da

ID gène: 563

NCBI Accession: NP_001176

UniProt: P25311

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process